Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules.


Journal

Pharmaceutical research
ISSN: 1573-904X
Titre abrégé: Pharm Res
Pays: United States
ID NLM: 8406521

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 12 02 2021
accepted: 23 03 2021
pubmed: 9 4 2021
medline: 9 11 2021
entrez: 8 4 2021
Statut: ppublish

Résumé

Current preclinical therapeutic strategies involving nanomedicine require increasingly sophisticated nanosystems and the characterization of the complexity of such nanoassemblies is becoming a major issue. Accurate characterization is often the factor that can accelerate the translational approaches of nanomedicines and their pharmaceutical development to reach the clinic faster. We conducted a case study involving the adsorption of the NFL-TBS.40-63 (NFL) peptide (derived from neurofilaments) to the surface of lipid nanocapsules (LNCs) (a combined nanosystem used to target glioblastoma cells) to develop an analytical approach combining the separation and the quantification in a single step, leading to the characterization of the proportion of free peptide and thus the proportion of peptide adsorbed to the lipid nanocapsule surface. LNC suspensions, NFL peptide solution and LNC/NFL peptide mixtures were characterized using a Size-Exclusion Chromatography method (with a chromatographic apparatus). In addition, this method was compared to centrifugal-filtration devices, currently used in literature for this case study. Combining the steps for separation and characterization in one single sequence improved the accuracy and robustness of the data and led to reproducible results. Moreover the data deviation observed for the centrifugal-filtration devices demonstrated the limits for this increasingly used characterization approach, explained by the poor separation quality and highlighting the importance for the method optimization. The high potential of the technique was shown, proving that H-bond and/or electrostatic interactions mediate adsorption of the NFL peptide to the surface of LNCs. Used only as a characterization tool, the process using chromatographic apparatus is less time and solvent consuming than classical Size-Exclusion Chromatography columns only used for separation. It could be a promising tool for the scientific community for characterizing the interactions of other combinations of nanosystems and active biological agents.

Identifiants

pubmed: 33829340
doi: 10.1007/s11095-021-03034-8
pii: 10.1007/s11095-021-03034-8
pmc: PMC8026175
doi:

Substances chimiques

Drug Carriers 0
Lipids 0
NFL-TBS.40-63 peptide 0
Nanocapsules 0
Neurofilament Proteins 0
Peptide Fragments 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

681-691

Références

J Phys Chem A. 2012 May 3;116(17):4338-47
pubmed: 22356446
Int J Nanomedicine. 2012;7:3517-26
pubmed: 22848175
J Control Release. 2019 Aug 10;307:302-314
pubmed: 31260754
J Phys Chem B. 2019 Dec 19;123(50):10622-10630
pubmed: 31790254
Mol Ther. 2012 Jul;20(7):1367-77
pubmed: 22491214
Acta Biomater. 2020 Jan 15;102:13-34
pubmed: 31759124
Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:859-867
pubmed: 30033321
Food Chem. 2018 Nov 15;266:133-145
pubmed: 30381168
Pharmaceutics. 2018 Oct 23;10(4):
pubmed: 30360549
Adv Mater. 2020 Jan;32(3):e1806158
pubmed: 30773709
J Pharm Biomed Anal. 2016 Feb 20;120:106-11
pubmed: 26719981
Biomaterials. 2020 Feb;230:119653
pubmed: 31837824
Pharm Res. 2002 Jun;19(6):875-80
pubmed: 12134960
J Control Release. 2019 Jan 10;293:73-83
pubmed: 30465823
J Phys Chem B. 2007 Sep 20;111(37):10929-37
pubmed: 17718556
J Neurosci. 2009 Sep 2;29(35):11043-54
pubmed: 19726663
Int J Nanomedicine. 2012;7:2901-10
pubmed: 22787390
Pharm Nanotechnol. 2019;7(3):246-256
pubmed: 31020941
Int J Pharm. 2013 Oct 1;454(2):738-47
pubmed: 23603097
Eur J Pharm Biopharm. 2012 Aug;81(3):690-3
pubmed: 22561953
Nanomaterials (Basel). 2020 Feb 06;10(2):
pubmed: 32041219
ACS Nano. 2018 Nov 27;12(11):10636-10664
pubmed: 30335963
Nutrients. 2019 Nov 07;11(11):
pubmed: 31703329
Eur J Pharm Biopharm. 2019 Jan;134:126-137
pubmed: 30472144
Eur J Pharm Biopharm. 2016 Jan;98:47-56
pubmed: 26522878
Int J Pharm. 2012 Sep 15;434(1-2):155-60
pubmed: 22643228
Talanta. 2017 Dec 1;175:200-208
pubmed: 28841979
J Pept Sci. 2019 May;25(5):e3146
pubmed: 30652389
Int J Pharm. 2016 Jun 15;506(1-2):191-200
pubmed: 27113868
Forensic Sci Int Genet. 2014 Nov;13:187-90
pubmed: 25173492
PLoS One. 2012;7(11):e49436
pubmed: 23152907
Biomaterials. 2013 Apr;34(13):3381-9
pubmed: 23391494
J Control Release. 2016 Sep 28;238:253-262
pubmed: 27503706
Nanomedicine (Lond). 2018 Mar 1;13(5):539-554
pubmed: 29381129
Adv Pharm Bull. 2020 Jan;10(1):1-12
pubmed: 32002356
Langmuir. 2007 Jul 3;23(14):7695-9
pubmed: 17564471
Adv Drug Deliv Rev. 2019 Jul;147:2-21
pubmed: 30769047
Drug Des Devel Ther. 2016 Mar 01;10:911-25
pubmed: 27041995
Nanoscale. 2018 Jul 19;10(28):13485-13501
pubmed: 29972178

Auteurs

Claire Gazaille (C)

University of Angers, Inserm, CNRS, MINT, SFR ICAT, F-49000, Angers, France.

Marion Sicot (M)

University of Angers, Inserm, CNRS, MINT, SFR ICAT, F-49000, Angers, France.

Marthe Akiki (M)

University of Angers, Inserm, CNRS, MINT, SFR ICAT, F-49000, Angers, France.

Nolwenn Lautram (N)

University of Angers, Inserm, CNRS, MINT, SFR ICAT, F-49000, Angers, France.

Aurélien Dupont (A)

University of Rennes, CNRS, Inserm, BIOSIT, UMS 3480, US_S 018, F-35000, Rennes, France.

Patrick Saulnier (P)

University of Angers, Inserm, CNRS, MINT, SFR ICAT, F-49000, Angers, France.

Joël Eyer (J)

University of Angers, Inserm, CNRS, MINT, SFR ICAT, F-49000, Angers, France.

Guillaume Bastiat (G)

University of Angers, Inserm, CNRS, MINT, SFR ICAT, F-49000, Angers, France. guillaume.bastiat@univ-angers.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH